Erez O, Romero R, Jung E, Chaemsaithong P, Bosco M, Suksai M
Am J Obstet Gynecol. 2022; 226(2S):S786-S803.
PMID: 35177220
PMC: 8941666.
DOI: 10.1016/j.ajog.2021.12.001.
Romero R
Am J Obstet Gynecol. 2019; 220(5):420-427.e1.
PMID: 31076040
PMC: 6655553.
DOI: 10.1016/j.ajog.2019.03.020.
Docheva N, Romero R, Chaemsaithong P, Tarca A, Bhatti G, Pacora P
J Matern Fetal Neonatal Med. 2018; 32(13):2113-2136.
PMID: 29320948
PMC: 6070437.
DOI: 10.1080/14767058.2018.1427058.
Reichhardt M, Jarva H, Lokki A, Laivuori H, Vuorela P, Loimaranta V
PLoS One. 2016; 11(2):e0147867.
PMID: 26828433
PMC: 4734712.
DOI: 10.1371/journal.pone.0147867.
Gongora M, Wenger N
Int J Mol Sci. 2015; 16(10):23905-28.
PMID: 26473833
PMC: 4632731.
DOI: 10.3390/ijms161023905.
Endocan, a putative endothelial cell marker, is elevated in preeclampsia, decreased in acute pyelonephritis, and unchanged in other obstetrical syndromes.
Adekola H, Romero R, Chaemsaithong P, Korzeniewski S, Dong Z, Yeo L
J Matern Fetal Neonatal Med. 2014; 28(14):1621-32.
PMID: 25211383
PMC: 4412749.
DOI: 10.3109/14767058.2014.964676.
Pre-eclampsia part 1: current understanding of its pathophysiology.
Chaiworapongsa T, Chaemsaithong P, Yeo L, Romero R
Nat Rev Nephrol. 2014; 10(8):466-80.
PMID: 25003615
PMC: 5893150.
DOI: 10.1038/nrneph.2014.102.
Comparison of perinatal and maternal outcomes of severe preeclampsia, eclampsia, and HELLP syndrome.
Yildirim G, Gungorduk K, Aslan H, Gul A, Bayraktar M, Ceylan Y
J Turk Ger Gynecol Assoc. 2014; 12(2):90-6.
PMID: 24591969
PMC: 3939113.
DOI: 10.5152/jtgga.2011.22.
Preeclampsia: a link between trophoblast dysregulation and an antiangiogenic state.
Romero R, Chaiworapongsa T
J Clin Invest. 2013; 123(7):2775-7.
PMID: 23934119
PMC: 3999621.
DOI: 10.1172/JCI70431.
Plasma concentrations of angiogenic/anti-angiogenic factors have prognostic value in women presenting with suspected preeclampsia to the obstetrical triage area: a prospective study.
Chaiworapongsa T, Romero R, Korzeniewski S, Cortez J, Pappas A, Tarca A
J Matern Fetal Neonatal Med. 2013; 27(2):132-44.
PMID: 23687930
PMC: 4151529.
DOI: 10.3109/14767058.2013.806905.
Maternal plasma concentrations of sST2 and angiogenic/anti-angiogenic factors in preeclampsia.
Stampalija T, Chaiworapongsa T, Romero R, Chaemsaithong P, Korzeniewski S, Schwartz A
J Matern Fetal Neonatal Med. 2013; 26(14):1359-70.
PMID: 23488689
PMC: 6333087.
DOI: 10.3109/14767058.2013.784256.
Maternal plasma concentrations of angiogenic/antiangiogenic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and severe late preeclampsia.
Chaiworapongsa T, Romero R, Korzeniewski S, Kusanovic J, Soto E, Lam J
Am J Obstet Gynecol. 2013; 208(4):287.e1-287.e15.
PMID: 23333542
PMC: 4086897.
DOI: 10.1016/j.ajog.2013.01.016.
Late-onset preeclampsia is associated with an imbalance of angiogenic and anti-angiogenic factors in patients with and without placental lesions consistent with maternal underperfusion.
Soto E, Romero R, Kusanovic J, Ogge G, Hussein Y, Yeo L
J Matern Fetal Neonatal Med. 2011; 25(5):498-507.
PMID: 21867402
PMC: 3401571.
DOI: 10.3109/14767058.2011.591461.
Placental lesions associated with maternal underperfusion are more frequent in early-onset than in late-onset preeclampsia.
Ogge G, Chaiworapongsa T, Romero R, Hussein Y, Kusanovic J, Yeo L
J Perinat Med. 2011; 39(6):641-52.
PMID: 21848483
PMC: 3213694.
DOI: 10.1515/jpm.2011.098.
Maternal plasma concentrations of angiogenic/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia.
Chaiworapongsa T, Romero R, Alpay Savasan Z, Kusanovic J, Ogge G, Soto E
J Matern Fetal Neonatal Med. 2011; 24(10):1187-207.
PMID: 21827221
PMC: 3384532.
DOI: 10.3109/14767058.2011.589932.
Placental protein 13 (PP13/galectin-13) undergoes lipid raft-associated subcellular redistribution in the syncytiotrophoblast in preterm preeclampsia and HELLP syndrome.
Balogh A, Pozsgay J, Matko J, Dong Z, Kim C, Varkonyi T
Am J Obstet Gynecol. 2011; 205(2):156.e1-14.
PMID: 21596368
PMC: 3527099.
DOI: 10.1016/j.ajog.2011.03.023.
Microarray profiling reveals that placental transcriptomes of early-onset HELLP syndrome and preeclampsia are similar.
Varkonyi T, Nagy B, Fule T, Tarca A, Karaszi K, Schonleber J
Placenta. 2010; 32 Suppl:S21-9.
PMID: 20541258
PMC: 3917714.
DOI: 10.1016/j.placenta.2010.04.014.
Report of the Canadian Hypertension Society Consensus Conference: 1. Definitions, evaluation and classification of hypertensive disorders in pregnancy.
Helewa M, Burrows R, Smith J, Williams K, Brain P, Rabkin S
CMAJ. 1997; 157(6):715-25.
PMID: 9307560
PMC: 1228113.
Laboratory findings in hypertensive disorders of pregnancy.
Fitzgerald M, Floro C, Siegel J, Hernandez E
J Natl Med Assoc. 1996; 88(12):794-8.
PMID: 8990805
PMC: 2608132.
Measurement of antiphospholipid antibody by ELISA using purified beta 2-glycoprotein I in preeclampsia.
Yamamoto T, Yoshimura S, Geshi Y, Sasamori Y, Okinaga S, Kobayashi T
Clin Exp Immunol. 1993; 94(1):196-200.
PMID: 8403506
PMC: 1534358.
DOI: 10.1111/j.1365-2249.1993.tb06000.x.